Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2024
Archives
The future of personalised cardiovascular disease detection and monitoring
Professor Allan Lawrie from Imperial College London, discusses the future of personalised cardiovascular disease detection and monitoring, including comment on wearable technology and AI.
Breast cancer prevention: Precision medicine and health
Biobank Norway Project experts chart the journey from precision medicine to precision health when it comes to breast cancer prevention.
Personalized medicine beyond cancer: Impact on other diseases
With a focus on type 2 diabetes and Parkinson’s disease, Dr Priya Hays explores how personalized medicine approaches are impacting the development of therapies for other chronic conditions beyond cancer.
Personalized cancer medicines
Dr. Priya Hays, PhD, CEO and Science Writer at Hays Documentation Specialists, LLC, guides us through the world of personalized cancer medicines.
Recruiting retired specialists back into part-time practice via telemedicine
Richard J. Santen, MD, Emeritus Professor of Medicine at the University of Virginia in Charlottesville, Virginia, U.S., looks at how to recruit retired specialists to practice part-time via telemedicine.
Navigating health autonomy through self-care
Interest in self-care has exploded in recent years, highlighting its crucial role in shaping future healthcare systems. Imperial SCARU’s Dr Austen El-Osta discusses emerging trends, research priorities and self-care policy landscapes, advocating for a global movement towrds accessible and empowered health management.
Personalized medicine: “Tyranny of the gene”
Dr Priya Hays, Ph.D., CEO/Science Writer at Hays Documentation Specialists, LLC, responds to “Tyranny of the Gene.” Is personalized medicine a threat to public health? Not really, but yes, it’s an argument for price controls and perhaps more regulations; we hear.
Bacteriophages: Nature’s remedy for tackling superbugs and antimicrobial resistance
Given the increasing threat of antimicrobial resistance, Gunther Vanwezer, CEO of Vésale Bioscience, explains how bacteriophages offer a promising natural solution and outlines the company’s efforts to become a pioneer in the development of innovative, personalised and sustainable phage-based therapy solutions.
Innovative dynamic molding to reduce development costs of personalized medicine
3Deus Dynamics has raised €2.5 million for the industrialization of its 3D process, to expand internationally and revolutionize personalized medicine with Dynamic Molding.
First international meeting towards eliminating paralysis after aortic aneurysm surgery
Professor Hamdy Awad, MD, FASA, from the Ohio State University Wexner Medical Center, examines the dangers of aortic aneurysm surgery and the importance of continued research towards eliminating paralysis.
The history of psychedelics and why psychedelic stories matter
Erika Dyck delves into the history of psychedelics, exploring how these substances have piqued the interest and influenced the attitudes of individuals across academia, culture, and medicine.
IC2PERMED: Fostering collaboration between Europe and China to enhance personalised medicine
Tailoring care to meet patients’ needs can dramatically improve clinical outcomes; we hear how the IC2PerMed project is bolstering efforts in personalised medicine.
RNA molecule signature diagnosis could revolutionize personalized medicine
Professor Michael Levin from Imperial College London argues that in the DIAMONDS project, there has been a breakthrough response in personalized medicine via RNA molecular signature diagnosis.
